Sign Up to like & get
recommendations!
0
Published in 2020 at "Developmental and comparative immunology"
DOI: 10.1016/j.dci.2020.103634
Abstract: C8α and C9 mediate the membrane attack complex formation and bacterial lysis and are important components in the complement system. The cDNA sequences of the C8α and C9 genes were cloned from Takifugu rubripes. The…
read more here.
Keywords:
terminal complement;
expression;
expression analysis;
analysis terminal ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15970
Abstract: Traumatic haemorrhage (TH) is the leading cause of potentially preventable deaths that occur during the prehospital phase of care. No effective pharmacological therapeutics are available for critical TH patients yet. Here, we identify terminal complement…
read more here.
Keywords:
immunopathology;
terminal complement;
complement;
survival ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.842023
Abstract: The early complement components have emerged as mediators of pro-oncogenic inflammation, classically inferred to cause terminal complement activation, but there are limited data on the activity of terminal complement in cancer. We previously reported elevated…
read more here.
Keywords:
terminal complement;
c5b;
complement;
eac ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Biomolecules"
DOI: 10.3390/biom13020216
Abstract: The terminal complement complex (TCC) has been described as a potential driver in the pathogenesis of posttraumatic osteoarthritis (PTOA). However, sublytic TCC deposition might also play a crucial role in bone development and regeneration. Therefore,…
read more here.
Keywords:
terminal complement;
complement complex;
bone;
loss ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Viruses"
DOI: 10.3390/v13122429
Abstract: Eculizumab, a terminal complement (C5)-inhibiting monoclonal antibody, was administered in five mechanically ventilated patients in life-threatening condition due to COVID-19-related acute respiratory distress syndrome (ARDS) between 23 March 2020 and 3 April 2020. Their clinical…
read more here.
Keywords:
terminal complement;
distress syndrome;
respiratory distress;
covid related ... See more keywords